BAGS: a Bayesian adaptive group sequential trial design with subgroup-specific survival comparisons
From MaRDI portal
Recommendations
- Bayesian Response-Adaptive Designs for Basket Trials
- Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers
- A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups
- Bayesian adaptive designs for clinical trials
- A Bayesian adaptive design for two-stage clinical trials with survival data
Cites work
- A sharper Bonferroni procedure for multiple tests of significance
- A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups
- Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity
- Bayesian Nonparametric Nonproportional Hazards Survival Modeling
- Bayesian survival analysis
- Bayesian Survival Analysis With Nonproportional Hazards
- Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints
- Discrete Sequential Boundaries for Clinical Trials
- Estimation of the average hazard ratio
- Familywise error control in multi-armed response-adaptive trials
- Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
- Markov Beta and Gamma Processes for Modelling Hazard Rates
- Multiple Comparisons
- Reversible jump Markov chain Monte Carlo computation and Bayesian model determination
Cited in
(5)- A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups
- Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes
- Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers
- Categories, components, and techniques in a modular construction of basket trials for application and further research
- BIPSE: a biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpoint
This page was built for publication: BAGS: a Bayesian adaptive group sequential trial design with subgroup-specific survival comparisons
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5857110)